![]() |
VNDA | Vanda Pharmaceuticals Inc. |
Pharmaceutical Preparations |
Book value per $ invested | $ 1.96 |
Leverage | 16.10% |
Market Cap | $ 275.6m |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -16.3m |
Margin | -7.80% |
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia.